22 related articles for article (PubMed ID: 16488622)
1. Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies.
Dobrin A; Lindenbergh PL; Shi Y; Perica K; Xie H; Jain N; Chow A; Wolchok JD; Merghoub T; Sadelain M; Hamieh M
Nat Cancer; 2024 May; 5(5):760-773. PubMed ID: 38503896
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer.
Trüb M; Uhlenbrock F; Claus C; Herzig P; Thelen M; Karanikas V; Bacac M; Amann M; Albrecht R; Ferrara-Koller C; Thommen D; Rothschield S; Savic Prince S; Mertz KD; Cathomas G; Rosenberg R; Heinzelmann-Schwarz V; Wiese M; Lardinois D; Umana P; Klein C; Laubli H; Kashyap AS; Zippelius A
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32616554
[TBL] [Abstract][Full Text] [Related]
3. Targeting and killing of glioblastoma with activated T cells armed with bispecific antibodies.
Zitron IM; Thakur A; Norkina O; Barger GR; Lum LG; Mittal S
BMC Cancer; 2013 Feb; 13():83. PubMed ID: 23433400
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts.
Hügle T; O'Reilly S; Simpson R; Kraaij MD; Bigley V; Collin M; Krippner-Heidenreich A; van Laar JM
Arthritis Rheum; 2013 Feb; 65(2):481-91. PubMed ID: 23045159
[TBL] [Abstract][Full Text] [Related]
5. 4-1BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1.
Lee HW; Nam KO; Park SJ; Kwon BS
Eur J Immunol; 2003 Aug; 33(8):2133-41. PubMed ID: 12884287
[TBL] [Abstract][Full Text] [Related]
6. 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation.
Shin SM; Kim YH; Choi BK; Kwon PM; Lee HW; Kwon BS
J Leukoc Biol; 2007 Jun; 81(6):1455-65. PubMed ID: 17389581
[TBL] [Abstract][Full Text] [Related]
7. Co-stimulation of antigen-specific CD4 T cells by 4-1BB ligand.
Gramaglia I; Cooper D; Miner KT; Kwon BS; Croft M
Eur J Immunol; 2000 Feb; 30(2):392-402. PubMed ID: 10671194
[TBL] [Abstract][Full Text] [Related]
8. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
Habib-Agahi M; Phan TT; Searle PF
Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
[TBL] [Abstract][Full Text] [Related]
9. 4-1BB-mediated amelioration of experimental autoimmune uveoretinitis is caused by indoleamine 2,3-dioxygenase-dependent mechanisms.
Choi BK; Asai T; Vinay DS; Kim YH; Kwon BS
Cytokine; 2006 Jun; 34(5-6):233-42. PubMed ID: 16899371
[TBL] [Abstract][Full Text] [Related]
10. Cross-linking of 4-1BB up-regulates IL-13 expression in CD8(+) T lymphocytes.
Nam KO; Shin SM; Lee HW
Cytokine; 2006 Jan; 33(2):87-94. PubMed ID: 16488622
[TBL] [Abstract][Full Text] [Related]
11. Dual immunoregulatory pathways of 4-1BB signaling.
Vinay DS; Cha K; Kwon BS
J Mol Med (Berl); 2006 Sep; 84(9):726-36. PubMed ID: 16924475
[TBL] [Abstract][Full Text] [Related]
12. Role of 4-1BBL and TRAF1 in the CD8 T cell response to influenza virus and HIV.
Watts TH; Lin GH; Wang C; McPherson AJ; Snell LM; Sabbagh L
Adv Exp Med Biol; 2011; 691():177-86. PubMed ID: 21153322
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
